OAN Newsroom
UPDATED 3:15 PM PT – Thursday, June 10, 2021
Researchers in New Jersey discover treating patients with higher levels of hydroxychloroquine increases COVID patient survival by up to 200 percent. One America’s Pearson Sharp has more.
MORE NEWS: Calif. Appealing Court Decision To Overturn Ban On Assault Weapons
SHARE